ClinicalTrials.gov
public full text
Public Domain
V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)
The study evaluates the immunogenicity, safety and tolerability of V501 in preadolescent females
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Meeting of the Strategic Advisory Group of Experts on Immunization, March 2026: conclusions and recommendations#256584
- Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age#966508
- Safety and Immunogenicity of CJ-50300#158048
- Reconsidering Inducing Immunity? A Reply to Our Critics.#364525
- A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.#829422
Record · ID 1138646
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive